 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Relationship between Blood Pressure and Death among Treated Hypertensive Patients at the High and Low Ends of Blood Pressure Control
19 March 2002 | Volume 136 Issue 6 | Page I49
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data." It is in the 19 March 2002 issue of Annals of Internal Medicine (volume 136, pages 438-448). The authors are F Boutitie, F Gueyffier, S Pocock, R Fagard, and JP Boissel. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians–American Society of Internal Medicine.
What is the problem and what is known about it so far?
Treatment of high blood pressure (hypertension) reduces the risk for heart attacks and death from cardiovascular disease. However, even people whose treatment has been effective remain at increased risk for death compared with persons without hypertension. Researchers have considered the possibility that although moderate reductions in blood pressure can save lives, further reductions may actually increase the death rate.
Why did the researchers do this particular study?
To find out whether decreasing blood pressure could be harmful in hypertensive patients.
Who was studied?
To create the study group for this analysis, the authors placed into one large computer file the study records of 40,233 hypertensive patients who had participated in seven different randomized clinical trials of treatment. Some of the patients had received medication (treated group) and some had received placebo (control group).
How was the study done?
The authors analyzed individual-patient data from all seven studies. In these studies, blood pressure had been measured at least once per year, and patients had been monitored for 2.2 to 5.8 years. The researchers recorded when a patient died of cardiovascular disease or other causes during the study period. They then calculated the risk for death in groups of patients with low, medium, and high blood pressure while they were receiving medication.
What did the researchers find?
1655 participants died during the follow-up period (56% died of cardiovascular causes and 44% died of noncardiovascular causes). On average, patients in the treated group had a lower diastolic blood pressure (the lower blood pressure value) than that of the control group. Death rates from all causes were higher in persons with high diastolic blood pressure and persons with low diastolic blood pressure than in persons in the middle range. This was seen in both treated and untreated patients. The death rate from noncardiovascular causes was particularly high in control patients with lower diastolic blood pressure. The researchers found no evidence of an increased risk for cardiovascular death with low systolic blood pressure (the higher number in the blood pressure measurement) in treated patients.
What were the limitations of the study?
Because the researchers did not measure other health factors affecting the patients, they could not test the possibility that poor general health, which itself is known to decrease blood pressure, might have increased the risk for death.
What are the implications of the study?
The increased risk for death seen in patients with low blood pressure is not likely to be related to excessive treatment because increased risk was also seen in untreated patients.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  P. Ruggenenti, E. Perticucci, P. Cravedi, V. Gambara, M. Costantini, S. K. Sharma, A. Perna, and G. Remuzzi Role of Remission Clinics in the Longitudinal Treatment of CKD J. Am. Soc. Nephrol., June 1, 2008; 19(6): 1213 - 1224. [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Fagard, J. A. Staessen, L. Thijs, H. Celis, C. J. Bulpitt, P. W. de Leeuw, G. Leonetti, J. Tuomilehto, and Y. Yodfat On-Treatment Diastolic Blood Pressure and Prognosis in Systolic Hypertension Arch Intern Med, September 24, 2007; 167(17): 1884 - 1891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Chobanian Isolated Systolic Hypertension in the Elderly N. Engl. J. Med., August 23, 2007; 357(8): 789 - 796. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Hypertension, August 1, 2007; 50(2): e28 - e55. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Rosendorff, H. R. Black, C. P. Cannon, B. J. Gersh, J. Gore, J. L. Izzo Jr, N. M. Kaplan, C. M. O'Connor, P. T. O'Gara, and S. Oparil Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention Circulation, May 29, 2007; 115(21): 2761 - 2788. [Full Text] [PDF]
|
|
|
|
|
|
G. Y.H. Lip, L. Frison, M. Grind, and on behalf of the SPORTIF Investigators Effect of hypertension on anticoagulated patients with atrial fibrillation Eur. Heart J., March 2, 2007; 28(6): 752 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Daly, G. DeBacker, and K. Fox Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology: reply Eur. Heart J., December 1, 2006; 27(23): 2903 - 2903. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Stidley, W. C. Hunt, F. Tentori, D. Schmidt, M. Rohrscheib, S. Paine, E. J. Bedrick, K. B. Meyer, H. K. Johnson, P. G. Zager, et al. Changing Relationship of Blood Pressure with Mortality over Time among Hemodialysis Patients J. Am. Soc. Nephrol., February 1, 2006; 17(2): 513 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Berl and W. Henrich Kidney-Heart Interactions: Epidemiology, Pathogenesis, and Treatment Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 8 - 18. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Pohl, S. Blumenthal, D. J. Cordonnier, F. De Alvaro, G. DeFerrari, G. Eisner, E. Esmatjes, R. E. Gilbert, L. G. Hunsicker, J. B. L. de Faria, et al. Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial: Clinical Implications and Limitations J. Am. Soc. Nephrol., October 1, 2005; 16(10): 3027 - 3037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Berl, L. G. Hunsicker, J. B. Lewis, M. A. Pfeffer, J. G. Porush, J.-L. Rouleau, P. L. Drury, E. Esmatjes, D. Hricik, M. Pohl, et al. Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2170 - 2179. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Wang, J. A. Staessen, S. S. Franklin, R. Fagard, and F. Gueyffier Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome Hypertension, May 1, 2005; 45(5): 907 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kikuya, T. Ohkubo, K. Asayama, H. Metoki, T. Obara, S. Saito, J. Hashimoto, K. Totsune, H. Hoshi, H. Satoh, et al. Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study Hypertension, February 1, 2005; 45(2): 240 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Rinder, R. J. Spina, L. R. Peterson, C. J. Koenig, C. R. Florence, and A. A. Ehsani Comparison of effects of exercise and diuretic on left ventricular geometry, mass, and insulin resistance in older hypertensive adults Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R360 - R368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Rosand Hypertension and the brain: Stroke is just the tip of the iceberg Neurology, July 13, 2004; 63(1): 6 - 7. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Wong, M. D. Knudtson, R. Klein, B. E. K. Klein, and L. D. Hubbard A Prospective Cohort Study of Retinal Arteriolar Narrowing and Mortality Am. J. Epidemiol., May 1, 2004; 159(9): 819 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mikhail, D. Cope, A. V. Chobanian, and E. J. Roccella The JNC-7 Guidelines and the Optimal Target for Systolic Blood Pressure * Response Hypertension, May 1, 2004; 43(5): e31 - e31. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Mason, J. E. Manson, H. D. Sesso, C. M. Albert, M. J. Chown, N. R. Cook, P. Greenland, P. M Ridker, and R. J. Glynn Blood Pressure and Risk of Secondary Cardiovascular Events in Women: The Women's Antioxidant Cardiovascular Study (WACS) Circulation, April 6, 2004; 109(13): 1623 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Mange, H. I. Feldman, M. M. Joffe, K. Fa, and R. D. Bloom Blood Pressure and the Survival of Renal Allografts from Living Donors J. Am. Soc. Nephrol., January 1, 2004; 15(1): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Pastor-Barriuso, J. R. Banegas, J. Damian, L. J. Appel, and E. Guallar Systolic Blood Pressure, Diastolic Blood Pressure, and Pulse Pressure: An Evaluation of Their Joint Effect on Mortality Ann Intern Med, November 4, 2003; 139(9): 731 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gueyffier Editorial Comment--Secondary Prevention of Stroke: Beyond Meta-Analyses Stroke, November 1, 2003; 34(11): 2748 - 2749. [Full Text] [PDF]
|
|
|
|
|
|
C. D. Mulrow and R. R. Townsend Guiding Lights for Antihypertensive Treatment in Patients with Nondiabetic Chronic Renal Disease: Proteinuria and Blood Pressure Levels? Ann Intern Med, August 19, 2003; 139(4): 296 - 298. [Full Text] [PDF]
|
|
|
|
|
|
G. Simon J-Shaped Relationship in Hypertension Ann Intern Med, January 7, 2003; 138(1): 78 - 78. [Full Text] [PDF]
|
|
|
|
|
|
K. Gupta, S. Gupta, and J. D. Cohen Undertreatment of Hypertension: A Dozen Reasons Arch Intern Med, October 28, 2002; 162(19): 2246 - 2248. [Full Text] [PDF]
|
|
|
|
 |
|
 Low BP -- Not Just Lowered BP -- Increases Mortality Risk Journal Watch Cardiology, May 24, 2002; 2002(524): 2 - 2. [Full Text]
|
|
|
|
 |
|
 J-Shaped BP-Mortality Curve Not Solely Due to Treatment Journal Watch (General), March 29, 2002; 2002(329): 1 - 1. [Full Text]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
